Literature DB >> 2893640

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.

H Ahlman1, L Ahlund, A Dahlström, O Nilsson, G Skolnik, L E Tisell, U Tylén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2893640      PMCID： PMC2002399          DOI： 10.1038/bjc.1987.302

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

Review 1.  Pituitary effects of somatostatin.

Authors:  R Hall; M Snow; M Scanlon; B Mora; A Gomez-Pan
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

2.  Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle.

Authors:  M L Cohen; E Rosing; K S Wiley; I H Slater
Journal:  Life Sci       Date:  1978-10-23       Impact factor: 5.037

3.  Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.

Authors:  I Norheim; E Theodorsson-Norheim; E Brodin; K Oberg
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

4.  Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.

Authors:  L Krulich; A P Dhariwal; S M McCann
Journal:  Endocrinology       Date:  1968-10       Impact factor: 4.736

Review 5.  Somatostatin.

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

Review 6.  Somatostatin and the gastrointestinal tract.

Authors:  R Arnold; P G Lankisch
Journal:  Clin Gastroenterol       Date:  1980-09

7.  Rapid reversal of carcinoid crisis with a somatostatin analogue.

Authors:  L K Kvols; J K Martin; H M Marsh; C G Moertel
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

8.  The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin.

Authors:  J C Frölich; Z T Bloomgarden; J A Oates; J E McGuigan; D Rabinowitz
Journal:  N Engl J Med       Date:  1978-11-09       Impact factor: 91.245

9.  Release of serotonin from human carcinoid tumor cells in vitro and grown in the anterior eye chamber of the rat.

Authors:  O Nilsson; H Ahlman; L E Ericson; G Skolnik; A Dahlström
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

10.  Role of hepatic arterial embolisation in the carcinoid syndrome.

Authors:  P N Maton; M Camilleri; G Griffin; D J Allison; H J Hodgson; V S Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-01
View more
  5 in total

Review 1.  Somatostatin and analogues in the treatment of cancer. A review.

Authors:  B M Evers; D Parekh; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

Review 2.  Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Authors:  Jessica E Maxwell; Boris Naraev; Daniel M Halperin; Michael A Choti; Thorvardur R Halfdanarson
Journal:  Ann Surg Oncol       Date:  2022-02-14       Impact factor: 5.344

Review 3.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

4.  Development and characterization of a novel in vivo model of carcinoid syndrome.

Authors:  Lindsey N Jackson; L Andy Chen; Shawn D Larson; Scott R Silva; Piotr G Rychahou; Paul J Boor; Jing Li; Gilberto Defreitas; W Lane Stafford; Courtney M Townsend; B Mark Evers
Journal:  Clin Cancer Res       Date:  2009-03-31       Impact factor: 12.531

Review 5.  The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Authors:  Marcin Kosmalski; Sylwia Ziółkowska; Piotr Czarny; Janusz Szemraj; Tadeusz Pietras
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.